by Clinical Neuropsychologist | Tuesday, October 1, 2024 | Dementia
Abstract INTRODUCTION It is important to understand the socioeconomic and medical determinants of subjective cognitive decline (SCD) at a population level in the United States. METHODS The primary outcomes are state-level rates of SCD and SCD-related functional...
by Clinical Neuropsychologist | Tuesday, October 1, 2024 | Dementia
Abstract Blood-based biomarkers (BBM) for Alzheimer’s disease (AD) are being increasingly used in clinical practice to support an AD diagnosis. In contrast to traditional diagnostic modalities, such as amyloid positron emission tomography and cerebrospinal fluid...
by Clinical Neuropsychologist | Monday, September 30, 2024 | Dementia
Abstract INTRODUCTION Rare variants in ABCA1 increase the risk of developing Alzheimer’s disease (AD). ABCA1 facilitates the lipidation of apolipoprotein E (apoE). This study investigated whether microRNA-33 (miR-33)-mediated regulation of this ABCA1–APOE...
by Clinical Neuropsychologist | Saturday, September 28, 2024 | Dementia
Dementia, Volume 24, Issue 1, Page 23-39, January 2025. Background: Dementia does not merely affect individuals, the carer and the person living with dementia, but also has a profound impact on their spousal relationship. As such, this study aimed to gain a deeper...
by Clinical Neuropsychologist | Thursday, September 26, 2024 | Dementia
Abstract INTRODUCTION The multifactorial influence of repetitive transcranial magnetic stimulation (rTMS) on neuroplasticity in neural networks is associated with improvements in cognitive dysfunction and sleep disorders. The mechanisms of rTMS and the...
